0 268

Cited 0 times in

Allelotype analysis of hepatocellular carcinoma

DC Field Value Language
dc.contributor.author김호근-
dc.contributor.author박전한-
dc.date.accessioned2020-07-02T17:08:17Z-
dc.date.available2020-07-02T17:08:17Z-
dc.date.issued1998-
dc.identifier.issn0020-7136-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/176617-
dc.description.abstractTo elucidate the genetic events which may play important roles in hepatocarcinogenesis, we examined every non-acrocentric chromosome arm of 22 hepatocellular carcinomas (HCCs) for loss of heterozygosity (LOH) using 68 highly polymorphic microsatellite markers. Thirty-six (92%) of 39 chromosome arms showed LOH in at least one patient, however 3 chromosome arms, 2p, 2q, and 20q, did not show any LOH. High to moderate frequency of LOH (>30% of informative cases) was observed at chromosomes 1q (68.1%), 4q (72.7%), 8p (63.6%), 8q (77.3%), 10q (33.3%), 13q (40%), 14q (46.1%), 16q (59.1%), and 17p (46.2%). Among these, LOH on chromosomes 1q and 8q have not been previously identified in HCC. Our results suggest that novel tumor suppressor genes may be involved in the development and progression of HCC.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherWiley-Liss-
dc.relation.isPartOfINTERNATIONAL JOURNAL OF CANCER-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHAlleles*-
dc.subject.MESHCarcinoma, Hepatocellular/genetics*-
dc.subject.MESHChromosome Deletion-
dc.subject.MESHGenes, Tumor Suppressor-
dc.subject.MESHGenetic Markers-
dc.subject.MESHHumans-
dc.subject.MESHLiver Neoplasms/genetics*-
dc.subject.MESHLoss of Heterozygosity*-
dc.titleAllelotype analysis of hepatocellular carcinoma-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Pathology (병리학교실)-
dc.contributor.googleauthorZhe Piao-
dc.contributor.googleauthorChanil Park-
dc.contributor.googleauthorJeon-Han Park-
dc.contributor.googleauthorHoguen Kim-
dc.identifier.doi10.1002/(SICI)1097-0215(19980105)75:1<29::AID-IJC5>3.0.CO;2-3-
dc.contributor.localIdA01183-
dc.contributor.localIdA01641-
dc.relation.journalcodeJ01092-
dc.identifier.eissn1097-0215-
dc.identifier.pmid94266-
dc.identifier.urlhttp://onlinelibrary.wiley.com/doi/10.1002/(SICI)1097-0215(19980105)75:1%3C29::AID-IJC5%3E3.0.CO;2-3/abstract-
dc.contributor.alternativeNameKim, Hogeun-
dc.contributor.affiliatedAuthor김호근-
dc.contributor.affiliatedAuthor박전한-
dc.citation.volume75-
dc.citation.number1-
dc.citation.startPage29-
dc.citation.endPage33-
dc.identifier.bibliographicCitationINTERNATIONAL JOURNAL OF CANCER, Vol.75(1) : 29-33, 1998-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Microbiology (미생물학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.